Diabetes: Symptoms, Diagnosis, and Complications

Common early symptoms of diabetes include polyuria (excessive urination), polydipsia (excessive thirst), fatigue, and unexplained weight loss. These symptoms may develop over several weeks in newly diagnosed patients. If you experience multiple symptoms simultaneously, medical evaluation through blood glucose testing is recommended for confirmation.

Diabetes is confirmed through specific blood glucose thresholds. A fasting plasma glucose of 126 mg/dL or higher, or an oral glucose tolerance test showing plasma glucose levels of 200 mg/dL or higher, indicates diabetes. Additionally, an A1c level of 6.5% or greater, reflecting average blood sugar over three months, confirms the diagnosis.

Impaired fasting glucose (IFG) occurs when fasting plasma glucose ranges from 100-125 mg/dL, while diabetes is diagnosed at 126 mg/dL or higher. IFG represents an intermediate state indicating increased risk of progression to type 2 diabetes and higher cardiovascular disease risk, but does not yet meet diabetes diagnostic criteria.

Untreated diabetes can cause severe acute metabolic disturbances like diabetic ketoacidosis and hyperglycemic hyperosmolar state. Chronic complications include microvascular damage causing retinopathy, nephropathy, and neuropathy, plus macrovascular effects including myocardial infarction and stroke. Effective glucose management can prevent, delay, or reduce most of these complications.

Early detection enables timely intervention and treatment, delaying or preventing diabetes-related complications. The American Diabetes Association recommends screening adults over 45 years old or those with risk factors including high body mass index, physical inactivity, hypertension, and family history of type 2 diabetes. Many individuals with type 2 diabetes are asymptomatic at diagnosis, making screening crucial.

Latent autoimmune diabetes of adults (LADA) occurs in individuals with type 2 diabetes phenotype who possess islet cell autoantibodies, indicating autoimmune-mediated beta cell destruction. Unlike typical type 2 diabetes, LADA involves immune system attack on insulin-producing cells, representing a distinct pathophysiological mechanism despite similar clinical presentation.

Glucose homeostasis is categorized by fasting glucose and oral glucose tolerance test results. Normal homeostasis is below 100 mg/dL fasting; impaired fasting glucose ranges 100-125 mg/dL; impaired glucose tolerance shows 140-199 mg/dL at two hours post-glucose challenge. Understanding glucose homeostasis pancreatic islets and insulin secretion mechanisms helps clinicians identify at-risk patients before diabetes develops.